These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4045301)

  • 1. Weight loss improves lipoprotein lipid profiles in patients with hypercholesterolemia.
    Davis TA; Anderson EC; Ginsburg AV; Goldberg AP
    J Lab Clin Med; 1985 Oct; 106(4):447-54. PubMed ID: 4045301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
    Insull W; Davidson MH; Demke DM; Dujovne CA; Eckert SM; Ginsberg D; Goldberg AC; Hodis HN; Hughes TA; Kane JP
    Atherosclerosis; 1995 Jan; 112(2):223-35. PubMed ID: 7772081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
    Seplowitz AH; Smith FR; Berns L; Eder HA; Goodman DS
    Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G; Witztum J; Basich P
    Artery; 1982; 10(2):99-104. PubMed ID: 7092583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol.
    Stefanick ML; Mackey S; Sheehan M; Ellsworth N; Haskell WL; Wood PD
    N Engl J Med; 1998 Jul; 339(1):12-20. PubMed ID: 9647874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL; Schonfeld G; Weidman SW
    J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
    Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
    Weisweiler P
    Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB; Bell C; Olson L
    Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia.
    Lucas CP; Boldrin MN; Reaven GM
    Am J Cardiol; 2003 Apr; 91(8):961-4. PubMed ID: 12686336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
    Crouse JR; Grundy SM
    Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
    Valeri A; Gelfand J; Blum C; Appel GB
    Am J Kidney Dis; 1986 Dec; 8(6):388-96. PubMed ID: 3544820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipoprotein responses during active and stable weight reduction in reproductive obese females.
    Friedman CI; Falko JM; Patel ST; Kim MH; Newman HA; Barrows H
    J Clin Endocrinol Metab; 1982 Aug; 55(2):258-62. PubMed ID: 7085852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colestipol at varying dosage intervals in the treatment of moderate hypercholesterolaemia.
    Lyons D; Webster J; Fowler G; Petrie JC
    Br J Clin Pharmacol; 1994 Jan; 37(1):59-62. PubMed ID: 8148218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
    Crouse JR
    Am J Med; 1987 Aug; 83(2):243-8. PubMed ID: 3618626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.
    Vega GL; Grundy SM
    JAMA; 1987 Jan; 257(1):33-8. PubMed ID: 3537351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
    Kuo PT; Wilson AC; Kostis JB; Moreyra AE
    Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia.
    Superko HR; Greenland P; Manchester RA; Andreadis NA; Schectman G; West NH; Hunninghake D; Haskell WL; Probstfield JL
    Am J Cardiol; 1992 Jul; 70(2):135-40. PubMed ID: 1626496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia.
    Kurowska EM; Jordan J; Spence JD; Wetmore S; Piché LA; Radzikowski M; Dandona P; Carroll KK
    Clin Invest Med; 1997 Jun; 20(3):162-70. PubMed ID: 9189647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.